Arrayit Corporation Logo

Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.  - Powerful Science for Life™

Corporate - Media & Press

Company announces completion of the ArrayIt® Microarray Platform (AMP™).

Sunnyvale, CA, December 10, 2007 – On December 10th, Arrayit announced the completion of the ArrayIt® Microarray Platform (AMP™), providing its customers with a single source of instruments, tools, kits, and reagents required for microarray analysis. AMP™ customers enjoy access to a complete line of microarrayers and scanners, printing devices, hybridization hardware, glass substrate slides, purification kits, buffers, and other products that fully empower researchers in the pharmaceutical, diagnostics, government and academic sectors to manufacture and use DNA and protein microarrays. ArrayIt® also offers pre-printed content microarrays as well as microarray services for organizations wishing to outsource part of all of the microarray analysis process. The company believes that AMP™ bolsters the competitiveness of ArrayIt® products in the rapidly emerging life sciences marketplace.

Arrayit Founder and Executive Vice President Mr. Todd Martinsky spoke directly about the benefits of the ArrayIt® Microarray Platform. “We believe our company now provides the most versatile and powerful microarray platform available in the industry. Our universal biochemistry platform empowers researchers worldwide to manufacture and use DNA, protein, peptide, antibody, antigen, carbohydrate and tissue microarrays to advance the forefronts of research, medicine and agriculture. The fact that our customers can purchase all of the required products from a single vendor provides purchasing coherence and convenience and ensures high quality. AMP™ allows us to compete successfully with Affymetrix, Agilent, NimbleGen, Illumina, and other companies in our space. We have the added advantage that our open platform architecture allows our customers to utilize products such as content microarrays from Agilent, NimbleGen, and many other open platform providers. AMP™ provides a significant value proposition in an expanding life sciences market.”

About Arrayit
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley.  Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications.  Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services.  The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.

Contact
Investor Relations
Arrayit Corporation
Telephone: 408-744-1331
Email: investorrelations@arrayit.com
Web: www.arrayit.com
 

 

Copyright 1993-2017 Arrayit Corporation. All rights reserved.